Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Photodisruption of the inner limiting membrane enhances retinal ganglion cell neurite formation

Emma De Coster; Kaat De Clerck; Chloë De Clercq; Weiran Li; Bernd Vanmeerhaeghe; Kevin Braeckmans; Hanieh Hadady; Thomas Vincent Johnson; Katrien Remaut; Karen Peynshaert

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1611.

ARVO Annual Meeting Abstract June 2025

Vapor nanobubble-mediated photoablation of eye floaters using a trypan blue conjugate

Jonathan Tavernier; Pouria Ramezani; J. Sebag; Kevin Braeckmans; Félix Sauvage; Stefaan De Smedt

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2261.

ARVO Annual Meeting Abstract June 2024

Exploring ILM photodisruption as a tool to promote retinal ganglion cell replacement

Karen Peynshaert; Emma De Coster; Kevin Braeckmans; Thomas Vincent Johnson; Katrien Remaut

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4525.

ARVO Annual Meeting Abstract June 2024

Corneal endothelial cell transfection by photoporation of a ready-to-use hyaluronic acid gel

Bernd Vanmeerhaeghe; Kevin Braeckmans; Dimitri Roels; Stefaan De Smedt; Félix Sauvage

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4170.

ARVO Annual Meeting Abstract June 2023

ICG-mediated ILM photodisruption enhances AAV transduction following intravitreal injection in rabbits

Karen Peynshaert; Phuc Nguyen; Dongshan Yang; Kevin Braeckmans; Stefaan De Smedt; Yannis Mantas Paulus; Katrien Remaut

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2414.

ARVO Annual Meeting Abstract June 2023

Characterization of enhanced lipid nanoparticle delivery after photodisruption of the inner limiting membrane

Kaat De Clerck; Helena Vanluchene; Kevin Braeckmans; Stefaan De Smedt; Katrien Remaut; Karen Peynshaert

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2614.

ARVO Annual Meeting Abstract June 2023

Photoporation of the ocular surface for enhanced mRNA delivery

Félix Sauvage; Mike Wels; Phuc Nguyen; Dimitri Roels; Yannis M. Paulus; Kevin Braeckmans; Stefaan De Smedt

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3595.

ARVO Annual Meeting Abstract June 2022

Photodisruption of the ILM to enhance retinal drug delivery after intravitreal injection

Karen Peynshaert; Kaat De Clerck; Helena Vanluchene; Geraldine Accou; Félix Sauvage; An-Katrien Minnaert; Kevin Braeckmans; Stefaan De Smedt; Katrien Remaut

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1853.

ARVO Annual Meeting Abstract June 2021

Gold nanoparticles for the treatment of eye floaters by light-induced vapor nanobubbles

Félix Sauvage; Van Phuc Nguyen; J Sebag; Juan Fraire; Katrien Remaut; Kevin Braeckmans; Yannis Mantas Paulus; Stefaan De Smedt

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3307.

ARVO Annual Meeting Abstract June 2021

ICG-mediated photoporation of the ILM to enhance retinal drug delivery after intravitreal injection

Karen Peynshaert; Kaat De Clerck; Félix Sauvage; An-Katrien Minnaert; Kevin Braeckmans; Stefaan De Smedt; Katrien Remaut

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1183.

ARVO Annual Meeting Abstract June 2021

Photoporation of the corneal epithelium with biocompatible poly-dopamine nanoparticles for the delivery of biologics

Mike Wels; Félix Sauvage; Koen Raemdonck; Dimitri Roels; Kevin Braeckmans; Stefaan De Smedt

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):866.

ARVO Annual Meeting Abstract September 2016

Study into the role of Müller cells in nanoparticle-based retinal gene therapy after intravitreal injection

Karen Peynshaert; Stefaan De Smedt; Kevin Braeckmans; Katrien Remaut

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):784.

Biochemistry and Molecular Biology October 2005

Vitreous: A Barrier to Nonviral Ocular Gene Therapy

PDF

Liesbeth Peeters; Niek N. Sanders; Kevin Braeckmans; Koen Boussery; Johan Van de Voorde; Stefaan C. De Smedt; Joseph Demeester
TAGS: vitreous body, mobility, polystyrenes, gene therapy, fluorescein-5-isothiocyanate
Invest. Ophthalmol. Vis. Sci.. 2005; 46(10):3553-3561. https://doi.org/10.1167/iovs.05-0165

Advertisement